Induction chemotherapy (IC) followed by radiotherapy (RT) versus cetuximab plus IC and RT in advanced laryngeal/hypopharyngeal cancer resectable only by total laryngectomy-final results of the larynx organ preservation trial DeLOS-II
A. Dietz*, G. Wichmann, T. Kuhnt, L. Pfreundner, R. Hagen, M. Scheich, O. Kölbl, M. G. Hautmann, J. Strutz, F. Schreiber, U. Bockmühl, V. Schilling, P. Feyer, M. De Wit, G. Maschmeyer, M. Jungehülsing, U. Schroeder, B. Wollenberg, C. Sittel, M. Münter
*Corresponding author for this work
- University of Leipzig
- University of Würzburg
- University of Regensburg
- Klinikum Kassel
- Ernst von Bergmann Hospital
- Hannover Medical School
- University of Giessen
- Friedrich Schiller University Jena
- ViDia Christliche Kliniken Karlsruhe
- RWTH Aachen University
- Nordstadt Krankenhaus
- HELIOS Klinikum Erfurt
- Karl-Franzens-University Graz
- Malteser Hospital Duisburg
- Klinikum Bielefeld
- Klinikum Nordhausen
- Charite - Universitatsmedizin Berlin
- ClinAssess GmbH
81
Link opens in a new tab
Citations
(Scopus)